Skip to content

Research on the Impact of Allergic Rhinitis Development on Gut Microbiota and the Clinical Application of Related Products

Research on the Impact of Allergic Rhinitis Development on Gut Microbiota and the Clinical Application of Related Products

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098397
Enrollment
Unknown
Registered
2025-03-07
Start date
2025-03-07
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis

Interventions

Sponsors

The Second Clinical Medicine School of Ningxia Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnosis of AR in accordance with the 2022 guidelines for the diagnosis and treatment of allergic rhinitis; 2.>=18 years; 3. Have not received any treatment for AR in the 3 months prior to enrollment; 4. Able to cooperate with testing.

Exclusion criteria

Exclusion criteria: 1. Concomitant autoimmune diseases; 2. One month before the inclusion of the study, the use of drugs that have an impact on the intestinal flora and immunity, such as hormones, antibiotics, probiotics, etc.; 3. Accompanied by major organic diseases such as tumors; 4. Concomitant gastrointestinal disorders.

Design outcomes

Primary

MeasureTime frame
IL-17;IL-10;Serum zinc;Gut microbiota;Baterial metabolites;

Countries

China

Contacts

Public ContactRuixia Ma

The First People's Hospital of Yinchuan

q921014489@163.com+86 951 619 2223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026